Pfizer Venture Investments logo

Pfizer Venture Investments

North America, New York, United States, New York

Description

Pfizer Venture Investments is a corporate venture capital firm that invests in areas of current or future strategic interest to Pfizer.

Investor Profile

Pfizer Venture Investments has made 166 investments, with 7 in the past 12 months and 28% as lead.

Stage Focus

  • Series B (31%)
  • Series A (28%)
  • Series C (15%)
  • Series Unknown (13%)
  • Seed (4%)
  • Series D (4%)
  • Series E (1%)
  • Post Ipo Equity (1%)
  • Series G (1%)
  • Series F (1%)

Country Focus

  • United States (77%)
  • United Kingdom (10%)
  • Switzerland (4%)
  • Canada (3%)
  • The Netherlands (2%)
  • France (1%)
  • Sweden (1%)
  • Belgium (1%)
  • Israel (1%)
  • China (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Medical Device
  • Oncology
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pfizer Venture Investments frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 12
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 19
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 18
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 11
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 11
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 13
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 18
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 11
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 13
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 11

Which angels does Pfizer Venture Investments often collaborate with?

Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
JB
North America, California, United States, San Francisco
Shared Deals: 1
BG
North America, Washington, United States, Seattle
Shared Deals: 3
TA
North America, Massachusetts, United States, Cambridge
Shared Deals: 2
Matthew Winkler
North America, Texas, United States, Austin
Shared Deals: 1
GM
North America, Texas, United States, Houston
Shared Deals: 1
CB
North America, California, United States, San Francisco
Shared Deals: 1
AP
North America, New Jersey, United States, Hackensack
Shared Deals: 1
ES
North America, New Jersey, United States, Princeton
Shared Deals: 1

What are some of recent deals done by Pfizer Venture Investments?

TRIMTECH Therapeutics

Cambridge, Massachusetts, United States

TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.

BiotechnologyMedicalTherapeutics
SeedMar 5, 2025
Amount Raised: $31,000,000
Normunity

New Haven, Connecticut, United States

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

BiotechnologyMedicalOncologyTherapeutics
Series BJan 13, 2025
Amount Raised: $75,000,000
TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology
Series BNov 13, 2024
Amount Raised: $84,000,000
Enara Bio

London, England, United Kingdom

Ervaxx is illuminating the immune interface to develop new cancer therapies.

BiotechnologyHealth CareTherapeutics
Series BOct 3, 2024
Amount Raised: $32,500,000
ImmunOs Therapeutics

Schlieren, Zurich, Switzerland

ImmunOs Therapeutics is a clinical-stage biotechnology company.

BiotechnologyHealth CarePharmaceutical
Series CSep 17, 2024
Amount Raised: $11,000,000
Autobahn Therapeutics

San Diego, California, United States

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

BiotechnologyHealth CareLife ScienceTherapeutics
Series CJul 24, 2024
Amount Raised: $100,000,000
Grey Wolf Therapeutics

Abingdon, Oxfordshire, United Kingdom

First-of-its-kind antigen modulation to address immune dysfunction in oncology and autoimmunity

BiotechnologyHealth CareTherapeutics
Series BMay 23, 2024
Amount Raised: $50,000,000
Capstan Therapeutics

San Diego, California, United States

Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.

BiotechnologyHealth CareTherapeutics
Series BMar 20, 2024
Amount Raised: $175,000,000
MISSION Therapeutics

Cambridge, Cambridgeshire, United Kingdom

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series DMar 14, 2024
Amount Raised: $32,118,400
Curve Therapeutics

Southampton, Southampton, United Kingdom

Curve develops an innovative screening platform.

Biotechnology
Series AFeb 27, 2024
Amount Raised: $51,355,077